Bethel, CT, United States of America

Glen Coburn

USPTO Granted Patents = 6 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Glen Coburn: A Pillar of Innovation in Pharmaceuticals

Introduction

Glen Coburn, based in Bethel, CT, is a prominent inventor in the pharmaceutical industry. With a remarkable portfolio of 6 patents, he has significantly contributed to advancements in treating viral infections, particularly those caused by coronaviruses. His work is instrumental in developing innovative therapeutic options that address urgent health challenges.

Latest Patents

Among his latest inventions are orally-bioavailable nucleoside analogs that have been described for their potential in treating coronavirus infections, including SARS-CoV-2. These compounds and their pharmaceutical compositions offer promising solutions to combat the ongoing impact of viral diseases, demonstrating Glen's commitment to finding effective treatments.

Career Highlights

Glen Coburn is affiliated with Venatorx Pharmaceuticals, Inc., where his research and inventions continue to thrive. His expertise and visionary approach have made him a crucial asset in the field of pharmaceutical innovation. His contributions not only reflect his drive for excellence but also his dedication to improving public health.

Collaborations

Throughout his career, Glen has collaborated with talented individuals such as Christopher J Burns and Steven Armen Boyd. These partnerships enhance the synergy in his research endeavors, allowing for a diverse exchange of ideas and expertise that propel the development of groundbreaking treatments.

Conclusion

Glen Coburn stands out as an influential inventor, making strides in the pharmaceutical sector. His dedication to innovation is evident through his patents and collaborative efforts, paving the way for advanced therapies that hold potential for treating significant health concerns. As he continues his work, Glen's contributions will undoubtedly leave a lasting impact on the industry and the lives of those affected by viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…